PERCEPTIVE ADVISORS LLC 13D and 13G filings for Verona Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:50 pm Purchase | 2024-09-30 | 13G | Verona Pharma plc VRNA | PERCEPTIVE ADVISORS LLC | 6,565,933 8.100% | 1,447,788 (+28.29%) | Filing |
| 2024-07-29 9:43 pm Purchase | 2024-07-17 | 13G | Verona Pharma plc VRNA | PERCEPTIVE ADVISORS LLC | 5,118,145 6.300% | 1,251,931 (+32.38%) | Filing |
| 2024-02-14 4:27 pm Sale | 2023-12-31 | 13G | Verona Pharma plc VRNA | PERCEPTIVE ADVISORS LLC | 3,866,214 4.800% | -596,452 (-13.37%) | Filing |
| 2023-04-20 5:01 pm Purchase | 2023-04-18 | 13G | Verona Pharma plc VRNA | PERCEPTIVE ADVISORS LLC | 4,462,666 5.600% | 4,462,666 (New Position) | Filing |